Dr Claire Homan
Research Fellow
Centre for Cancer Biology
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Homan is a research fellow at the Centre for Cancer Biology, with a strong track-record of multi-disciplinary research spanning human genetics, genomics, haematological malignancies and developmental biology. Her research has provided impactful contributions to understanding genetic disease mechanisms including clinical, genetic, and functional evidence of novel-gene pathogenicity. Dr. Homan’s research in inherited haematological malignancies has a focus on elucidating biological mechanisms driving disease progression and development to apply a personalised-medicine approach to patient care. Her overarching objective is to develop novel clinical interventions for enhanced monitoring, prevention, and therapy. Dr. Homan is pioneering work into the characterisation of genetic mouse models of predisposition to MDS/AML and developing translational models for the development of novel therapies.
| Date | Position | Institution name |
|---|---|---|
| 2017 - ongoing | Research Associate | University of Adelaide, Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| University of Adelaide, Adelaide | Australia | PhD |
| Year | Citation |
|---|---|
| 2025 | Banaszak, L., Barredo, B., Wlodarski, M., Lewis, S., Ferrer, A., Patnaik, M., . . . Churpek, J. (2025). ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states. In BLOOD Vol. 146 (pp. 1440-1441). ELSEVIER. DOI |
| 2023 | Scott, H. S., Zerella, J., Homan, C., Arts, P., Lin, S., Spinelli, S. J., . . . Hahn, C. N. (2023). ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy. In BLOOD Vol. 144 (pp. LBA8). CA, San Diego: ELSEVIER. DOI WoS2 |
| 2022 | Saygin, C., Roloff, G. W., Hahn, C. N., Chhetri, R., Gill, S., Elmariah, H., . . . Godley, L. A. (2022). Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies. In BLOOD Vol. 140 (pp. 10542-10544). LA, New Orleans: ELSEVIER. DOI |
| 2019 | Homan, C., Armstrong, M., Dobbins, J., Lawrence, D., Wang, P., Arts, P., . . . Brown, A. (2019). DEVELOPMENT OF A DATA PORTAL FOR AGGREGATION AND ANALYSIS OF GENOMICS DATA IN FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCY - THE RUNX1.DB. In EXPERIMENTAL HEMATOLOGY Vol. 76 (pp. S69). ELSEVIER SCIENCE INC. |
| 2019 | Cheah, J., Brown, A., Eshraghi, L., Feng, J., Schreiber, A., Babic, M., . . . Scott, H. (2019). AN INTEGRATIVE GENOMIC APPROACH TO EXAMINE MUTATIONS AND BIOLOGICAL PATHWAYS ASSOCIATED WITH HAEMATOLOGICAL MALIGNANCY DEVELOPMENT IN DDX41 MUTATED FAMILIES. In EXPERIMENTAL HEMATOLOGY Vol. 76 (pp. S61). ELSEVIER SCIENCE INC. |
| 2019 | Venugopal, P., Cheah, J. J. C., Eshraghi, L., Shahrin, N. H., Homan, C., Feng, J., . . . Scott, H. S. (2019). An Integrative Genomic Approach to Examine Mutations and Biological Pathways Associated with Hematological Malignancy Development in DDX41 Mutated Families. In BLOOD Vol. 134 (pp. 3 pages). FL, Orlando: ELSEVIER. DOI WoS2 |
-
The missing heritability of rare diseases: discovery to implementation, Medical Research Future Fund, 01/01/2023 - 31/12/2027
-
Examining the pathogenic bone marrow microenvironment, HSC stress, and targeting clonal evolution to prevent development of leukaemia in predisposed individuals, Leukaemia Foundation - Grant in Aid (National Research Program), 10/07/2023 - 09/05/2025
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2023 | Co-Supervisor | 111117 - Examining the role of the pathogenic bone marrow microenvironment and hematopoietic stem cell stress in the development of leukaemia in blood cancer predisposition | - | Doctorate | Full Time | Saman Ghalamkari |